Korinna Karampampa

9PUBLICATIONS
19CO-AUTHORS
HaematologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 18, 2025
Budget impact analysis of Haemate-P as long-term prophylaxis and on-demand therapy for von Willebrand disease in Spain.

Michele R Wilson, Pablo Mendez, Cheryl L McDade

|May 16, 2023
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab.

Korinna Karampampa, Hanna Gyllensten, Emilie Friberg

|Jan 27, 2023
Cost-effectiveness of idecabtagene vicleucel compared with conventional care in triple-class exposed relapsed/refractory multiple myeloma patients in Canada and France.

Korinna Karampampa, Wenjie Zhang, Meena Venkatachalam

|Nov 23, 2022
Excess costs of multiple sclerosis: a register-based study in Sweden.

Chantelle Murley, Petter Tinghög, Fitsum Sebsibe Teni

|May 02, 2022
Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden.

Korinna Karampampa, Hanna Gyllensten, Chantelle Murley

|Aug 20, 2021
Observational study of the implementation of telephone advice nursing in Sweden: did callers follow recommendations and did the rate of healthcare visits change?

Amanda Sundberg, Anna Carin Wahlberg, Niklas Zethraeus

Pageof 2

Frequent Collaborators

5 joint publications

Chantelle Murley

3 joint publications

Jan Hillert

2 joint publications

Petter Tinghög

2 joint publications

Kristina Alexanderson